Chart of the Day 📈 8/21/25: Does THIS Mean it's Almost Time for Gold's NEXT Breakout?

Mike Larson | Editor-in-Chief

You can’t exactly set your clock to it. The timing isn’t 100% perfect. But throughout the gold bull market, we HAVE seen a fairly consistent pattern – and it suggests the metal’s NEXT breakout could be coming soon!

Take a look at the MoneyShow Chart of the Day. It shows the percentage change in the SPDR Gold Shares (GLD) in purple and the VanEck Gold Miners ETF (GDX) in orange. The timeframe is three years.

GLD, GDX (3-Year % Change)

Focus first on the past few times gold stagnated after a big upside run. Those periods of sideways chop lasted from around December 2023 to March 2024…May 2024 to August 2024...and October 2024 to January 2025. Each consolidation period began and ended at different times during those months. So, let’s call it three-to-four-months on average.

The current consolidation pattern started in late April. We’re in late August. So, yes, it has been about four months. Could a new breakout be coming...soon? Food for thought!

Now, look at the OTHER interesting thing on this chart – how gold MINERS have kept on climbing even as gold itself has traded largely sideways. That shows you “Big Money” – meaning a lot more “mainstream” fund managers – is buying into this bull market (after fighting it for far too long of course).

Could that be another signal that the underlying metal is ready to rip? No guarantees. But it certainly doesn’t seem bearish to me!

Bohnsack & Zhang: The Best Profit Opportunities - Whether You Trade Based on Macro or Micro Analysis

In this episode of the MoneyShow MoneyMasters Podcast, Nicholas Bohnsack, president and CEO of Strategas Securities, and Amy Zhang, executive vice president and portfolio manager at Alger, reveal the powerful currents driving markets in 2025. 

Nicholas breaks down the real implications of monetary policy moves, inflation trends, and labor market pressures – and shares his favorite investing themes. Meanwhile, Amy explains why and where small and mid-cap stocks are quietly outperforming, details how in-depth research can help drive results in the SMID space, and spotlights sectors and companies that are often overlooked.

Learn from Payne, Belski, Levine, & Shay — LIVE in Orlando!

👨‍🏫 Connect with top money experts like Charles Payne, Brian Belski, Alicia Levine, and Danielle Shay — LIVE at the 2025 MoneyShow/TradersEXPO Orlando. If you act now, you’ll qualify for “Early Bird” pricing, too!

📈 Get top stock and ETF picks, expert options trading help, big-picture macro insights, and deep-dive investing and trading education from Oct. 16-18!

⛳ Plus, enjoy all the golf, tennis, fine dining, kids’ programs, and other entertainment the luxurious Omni Orlando Resort at ChampionsGate offers!

• PLTR: An Example of How to Trade the "Red to Green" Concept
  👉️ TICKER: PLTR

  This recent selloff has created a window for traders who can ride a “Red to Green” concept, but not yet investors that depend on a steady grind higher with minimal position management post-entry. I’ll use Palantir Technologies Inc. (PLTR) to illustrate things, explains Larry Cheung, founder of Letters from Larry.

• IBB and XBI: Are These Biotech ETFs Worth Trading Here?

  👉️ TICKERS: XBI, IBB

  The healthcare sector has had a rough run in 2025. Biotech stocks are also feeling the pressure. But investors looking to diversify or find underpriced segments may want to revisit the space. To get a clearer picture, we’ll look at two popular biotech ETFs — the iShares Biotechnology ETF (IBB) and SPDR Biotech ETF (XBI), writes Tony Dong, lead ETF analyst at ETF Central.

☀️📈 Get year-end picks and strategies at the 2025 MoneyShow/TradersEXPO Orlando (Oct. 16-18). Registration is now OPEN!